NF-kappa-B decoy oligonucleotide

N/A

Report date: 2026/02/15 20:00:16
NME

Base Information

Drug NameNF-kappa-B decoy oligonucleotide
Drug Alias NameNF-kappa-B decoy oligo (AnGes MG)NF-kB decoy oligo (AnGes MG)NF-kappaB decoycupabimodNDON +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsDermatitis, AtopicIntervertebral Disc Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnges MgOsaka University
China Registration ClassN/A

Develop Information

Active CompaniesNippon Zoki Pharmaceutical Co LtdAnges MgOsaka University +[4] 
Inactive CompaniesAnges Inc
Active IndicationsDermatitis, Atopic
Inactive IndicationsIntervertebral Disc Degeneration

Other Information

ATC CodeN/A
Related LinksN/A